Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Maiwald Intellectual PropertyDr Gisela Grabow of Maiwald explains the importance of a comprehensive approach to the revision of pharmaceutical legislation that considers the relationship with IP rights and the Action Plan on IP -
Sponsored by Bird & BirdChris de Mauny of Bird & Bird discusses the current and future importance of sufficiency in light of recent UK case law
-
Sponsored by Lifang & PartnersYan Zhang and Lin Mu of Lifang & Partners discuss a Supreme People’s Court case that establishes the timeframe for damages awarded to trademark owners
-
Sponsored by Gün and PartnersAysel Korkmaz Yatkin and Aysu Eryaşar of Gun and Partners evaluate the position of Turkey’s IP courts in a case focusing on preliminary injunction assessments
-
Sponsored by Liu, Shen & AssociatesXiaoming Zhang and Haitao Li of Liu Shen & Associates describe how two cutting-edge technologies, 5G and artificial intelligence, are empowering each other
-
Sponsored by FB RiceJeremy Dobbin of FB Rice summarises the key changes implemented by the Design Amendment (Advisory Council on Intellectual Property Response) Act 2021 and advises when they take effect
